Target intelligence / Profile preview

Bacterial cytoplasmic membrane and cell envelope

Molecular classification
Other, Cell envelope, Lipid bilayer
01

Overview

The bacterial cytoplasmic membrane and associated cell envelope components constitute the fundamental structural barrier of prokaryotic cells, essential for maintaining osmotic pressure and cellular homeostasis (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). The cytoplasmic membrane is a phospholipid bilayer that serves as a scaffold for proteins involved in energy production, such as the electron transport chain, and the transport of nutrients and waste (Strahl & Hamoen, 2010, PNAS). In most bacteria, this membrane is protected by a cell envelope consisting of a peptidoglycan cell wall, which provides mechanical strength and prevents osmotic lysis (Vollmer et al., 2008, FEMS Microbiol Rev). In Gram-negative species, an additional outer membrane containing lipopolysaccharides provides an extra layer of protection against environmental stressors and antibiotics (Nikaido, 2003, Microbiol Mol Biol Rev). These structures are critical therapeutic targets; for instance, polymyxins and daptomycin directly disrupt membrane integrity, while beta-lactams and glycopeptides inhibit the synthesis of the cell wall (Silver, 2011, Clin Microbiol Rev). Because the composition of the bacterial cell envelope differs significantly from human cell membranes, it allows for the development of drugs with high selective toxicity, although the emergence of resistance remains a significant clinical challenge (Blair et al., 2015, Nat Rev Microbiol).

Other names
Bacterial inner membranePlasma membraneCell wallPeptidoglycan layerBacterial cell envelopeBacterial cytoplasmic membrane
02

Mechanism of action

Disruption of membrane integrity, pore formation, depolarization of the cytoplasmic membrane, and inhibition of cell wall (peptidoglycan) biosynthesis (Silver, 2011, Clin Microbiol Rev; Strahl & Hamoen, 2010, PNAS).

03

Biological functions

Permeability barrierEnergy transductionCell wall synthesisNutrient transportSignal transduction
04

Disease associations

InfectionSepsisPneumoniaUrinary tract infection
05

Safety considerations

NephrotoxicityNeurotoxicityMyopathyAntibiotic resistanceMicrobiome disruption
06

Interacting drugs

Polymyxin B

9 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Procalcitonin (PCT)C-reactive protein (CRP)Bacterial DNA load

Beyond the preview

Go deeper on Bacterial cytoplasmic membrane and cell envelope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cytoplasmic membrane and cell envelope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call